- Home
- MAN vs ACAD Comparison
MAN vs ACAD Comparison
Compare MAN & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- ACAD
- Stock Information
- Founded
- MAN 1948
- ACAD 1993
- Country
- MAN United States
- ACAD United States
- Employees
- MAN N/A
- ACAD N/A
- Industry
- MAN Professional Services
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- MAN Consumer Discretionary
- ACAD Health Care
- Exchange
- MAN Nasdaq
- ACAD Nasdaq
- Market Cap
- MAN 2.8B
- ACAD 3.4B
- IPO Year
- MAN 1988
- ACAD 2004
- Fundamental
- Price
- MAN $53.78
- ACAD $19.95
- Analyst Decision
- MAN Hold
- ACAD Buy
- Analyst Count
- MAN 6
- ACAD 19
- Target Price
- MAN $69.33
- ACAD $25.33
- AVG Volume (30 Days)
- MAN 756.1K
- ACAD 1.6M
- Earning Date
- MAN 04-17-2025
- ACAD 02-26-2025
- Dividend Yield
- MAN 5.72%
- ACAD N/A
- EPS Growth
- MAN 71.02
- ACAD N/A
- EPS
- MAN 3.01
- ACAD 0.78
- Revenue
- MAN $17,853,900,000.00
- ACAD $929,236,000.00
- Revenue This Year
- MAN N/A
- ACAD $36.88
- Revenue Next Year
- MAN $3.70
- ACAD $8.01
- P/E Ratio
- MAN $17.86
- ACAD $25.70
- Revenue Growth
- MAN N/A
- ACAD 47.06
- 52 Week Low
- MAN $53.68
- ACAD $14.15
- 52 Week High
- MAN $78.87
- ACAD $26.56
- Technical
- Relative Strength Index (RSI)
- MAN 30.19
- ACAD 60.25
- Support Level
- MAN $53.71
- ACAD $19.52
- Resistance Level
- MAN $55.40
- ACAD $20.29
- Average True Range (ATR)
- MAN 1.27
- ACAD 0.68
- MACD
- MAN -0.34
- ACAD 0.08
- Stochastic Oscillator
- MAN 1.82
- ACAD 72.62
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that includes Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives maximum of the company's revenue. The company derives maximum geographical revenue from Southern European region.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.